Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
292
Period ended Jun 30, 2026
Change on a year earlier
-52.5%
615 in Q2 2025
History
65 quarters
Since Q4 2008
Sources
63
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Short-Term Investments ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 292 | -52.5% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 375 | -37.4% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 0 | -100.0% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 45 | – | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 615 | +1,130.0% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 599 | +1,397.5% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 447 | +77.4% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 0 | -100.0% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 50 | -93.0% | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 40 | -94.1% | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 252 | -49.4% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 168 | +63.1% | Form 10-Q (filed 2023-11-03) ↗ |
| Q2 2023 | Jun 30, 2023 | 718 | +58.5% | Form 10-Q (filed 2023-08-07) ↗ |
| Q1 2023 | Mar 31, 2023 | 680 | +82.8% | Form 10-Q (filed 2023-05-05) ↗ |
| Q4 2022 | Dec 31, 2022 | 498 | – | Form 10-K (filed 2023-02-24) ↗ |
| Q3 2022 | Sep 30, 2022 | 103 | – | Form 10-Q (filed 2022-11-03) ↗ |
| Q2 2022 | Jun 30, 2022 | 453 | – | Form 10-Q (filed 2022-08-05) ↗ |
| Q1 2022 | Mar 31, 2022 | 372 | – | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2021 | Dec 31, 2021 | 0 | – | Form 10-Q (filed 2022-05-05) ↗ |
| Q4 2020 | Dec 31, 2020 | 0 | -100.0% | Form 10-K (filed 2021-02-25) ↗ |
| Q3 2020 | Sep 30, 2020 | 0 | -100.0% | Form 10-Q (filed 2020-11-05) ↗ |
| Q2 2020 | Jun 30, 2020 | 0 | -100.0% | Form 10-Q (filed 2020-08-05) ↗ |
| Q1 2020 | Mar 31, 2020 | 7 | -99.0% | Form 10-Q (filed 2020-05-06) ↗ |
| Q4 2019 | Dec 31, 2019 | 774 | -13.9% | Form 10-K (filed 2020-02-26) ↗ |
| Q3 2019 | Sep 30, 2019 | 149 | -93.9% | Form 10-Q (filed 2019-11-05) ↗ |
| Q2 2019 | Jun 30, 2019 | 446 | -80.5% | Form 10-Q (filed 2019-08-06) ↗ |
| Q1 2019 | Mar 31, 2019 | 722 | -74.8% | Form 10-Q (filed 2019-05-08) ↗ |
| Q4 2018 | Dec 31, 2018 | 899 | -62.6% | Form 10-K (filed 2019-02-27) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,459 | -25.3% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,284 | -45.4% | Form 10-Q (filed 2018-08-07) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,863 | -19.1% | Form 10-Q (filed 2018-05-08) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,406 | -69.3% | Form 10-K (filed 2018-02-27) ↗ |
| Q3 2017 | Sep 30, 2017 | 3,294 | -36.2% | SEC Filing ↗ |
| Q2 2017 | Jun 30, 2017 | 4,181 | -20.0% | SEC Filing ↗ |
| Q1 2017 | Mar 31, 2017 | 3,541 | +9.7% | SEC Filing ↗ |
| Q4 2016 | Dec 31, 2016 | 7,826 | +59.6% | SEC Filing ↗ |
| Q3 2016 | Sep 30, 2016 | 5,160 | +13.6% | SEC Filing ↗ |
| Q2 2016 | Jun 30, 2016 | 5,226 | +17.5% | SEC Filing ↗ |
| Q1 2016 | Mar 31, 2016 | 3,227 | -57.7% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 4,903 | -40.8% | Form 10-K (filed 2016-02-26) ↗ |
| Q3 2015 | Sep 30, 2015 | 4,541 | +52.5% | Form 10-Q (filed 2015-11-05) ↗ |
| Q2 2015 | Jun 30, 2015 | 4,448 | +21.8% | Form 10-Q (filed 2015-08-06) ↗ |
| Q1 2015 | Mar 31, 2015 | 7,621 | +62.7% | Form 10-Q (filed 2015-05-07) ↗ |
| Q4 2014 | Dec 31, 2014 | 8,278 | +343.9% | Form 10-K (filed 2015-02-27) ↗ |
| Q3 2014 | Sep 30, 2014 | 2,977 | -27.0% | Form 10-Q (filed 2014-11-10) ↗ |
| Q2 2014 | Jun 30, 2014 | 3,652 | – | Form 10-Q (filed 2014-08-07) ↗ |
| Q1 2014 | Mar 31, 2014 | 4,685 | +56.3% | Form 10-Q (filed 2014-05-08) ↗ |
| Q4 2013 | Dec 31, 2013 | 1,865 | -30.7% | Form 10-K (filed 2014-02-27) ↗ |
| Q2 2013 | Sep 30, 2013 | 4,079 | +438.8% | Form 10-Q (filed 2013-11-07) ↗ |
| Q1 2013 | Mar 31, 2013 | 2,998 | +229.5% | Form 10-Q (filed 2013-05-09) ↗ |
| Q4 2012 | Dec 31, 2012 | 2,690 | +86.7% | Form 10-K (filed 2013-02-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 757 | -42.8% | Form 10-Q (filed 2012-11-09) ↗ |
| Q2 2012 | Jun 30, 2012 | 698 | -57.4% | Form 10-Q (filed 2012-08-07) ↗ |
| Q1 2012 | Mar 31, 2012 | 910 | – | Form 10-Q (filed 2012-05-08) ↗ |
| Q4 2011 | Dec 31, 2011 | 1,441 | +10.8% | Form 10-K (filed 2012-02-28) ↗ |
| Q3 2011 | Sep 30, 2011 | 1,323 | +76.3% | Form 10-Q (filed 2011-11-08) ↗ |
| Q2 2011 | Jun 30, 2011 | 1,639 | +28.3% | Form 10-Q (filed 2011-08-08) ↗ |
| Q4 2010 | Dec 31, 2010 | 1,301 | +344.0% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 750 | +54.1% | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 1,277 | -9.5% | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 1,541 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 293 | -73.8% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2009 | Sep 30, 2009 | 487 | – | Form 10-Q (filed 2009-10-29) ↗ |
| Q2 2009 | Jun 30, 2009 | 1,411 | – | Form 10-Q (filed 2009-07-24) ↗ |
| Q4 2008 | Dec 31, 2008 | 1,118 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Short-Term Investments ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_sti
See every metric in the Merck KPI table. Data updated Oct 26, 2026.